Ophthalmic Complications Observed After Use of GLP-1 Agonists

(MedPage Today) – Although it was not possible to determine causation, a series of cases retroactively identified nine patients who have developed ophthalmia during treatment with semiconductide (OzemPIC, Wegovy) or Tirzepatide (Mounjaro, Zepbound …